CA Stock MarketDetailed Quotes

Cosciens Biopharma Inc (CSCI)

Watchlist
  • 3.030
  • -0.950-23.87%
15min DelayMarket Closed Apr 8 16:00 ET
9.65MMarket Cap-0.68P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cosciens Biopharma Inc (CSCI) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
Active ingredient7.04M93.85%
Pharmaceutical461K6.15%

By Product

No Data

By Industry

No Data

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
United States4.6M61.40%
Germany2.38M31.72%
United Kingdom457K6.09%
Other59K0.79%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 -0.75%
Sample Name
Sample Code
 -3.78%
Sample Name
Sample Code
 -5.81%
4
CHINA OILFIELD
02883
-6.57%
5
KUNLUN ENERGY
00135
-11.88%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.84%
Sample Name
Sample Code
 +15.60%
Sample Name
Sample Code
 +6.95%
4
Hangzhou Shunwang Technology
300113
-4.18%
5
Rockchip Electronics
603893
-9.45%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The US-Iran situation has reached a major turning point as Trump announced a two-week suspension of military actions against Iran, with both Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -